Go to Top

Tag Archives

Tag Archives: SGYP

Synergy Pharmaceuticals, Inc. (SGYP): Positive Results From Plecanatide Phase IIb/III Trial

Synergy Pharmaceuticals, Inc. (SGYP) today announced that plecanatide, its investigational oral drug for the treatment of chronic idiopathic constipation (CIC), was well tolerated and met the primary and key secondary endpoints of a Phase IIb/III clinical study. Full study results will be presented at a major scientific meeting this year. The randomized, double-blind, placebo-controlled, repeat-dose, …Read More